Pharma sued by 23,600 persons over 30 years NO case went to trial !

[Guest guest]

Pharma sued by 23,600 persons over 30 years NO case went to trial !

(The only winners, it seems, are the fat cat lawyers)

here is an Atypical fat cat but there are many others"In a succession of major English cases from the mid 1970's, a total of around 23,600 claimants brought claims in a succession of multiparty claims against manufacturers involving DTP vaccine, Opren, Myodil contrast media, benzodiazepine tranqullizers and the Norplant subcutaneous contraceptive (Hodges, 1999). However, no case proceeded as far as a final trial on liability. The failure of the DTP vaccine, tranquillizer and Norplant litigation in the UK can be contrasted with the fact that the manufacturers settled similar claims in the USA at enormous cost in order to avoid even greater costs of years of litigation. In 2000, a case was heard relating to the failure of a condom resulting in pregnancy, but the judge held that the defendant's in the case had never claimed that a condom was 100% effective, and therefore the claim failed. "1 In March 2001, the first ever successful UK product-related class action (source - http://www.ippa.ws/IPPC1/BOOK/Chapter_15.pdfA v National Blood Authority [2001] 3 All E.R. 289) under the Consumer Protection Act strict liability was decided, when six test cases (representing a total of 114 claimants) obtained awards of up to £210,000 from Hepatitis C infection from NHS blood transfusions. Goldberg (2002) notes the implications of this case, as it was the first opportunity of its kind in the UK to assess the problem of strict medicinal product liability in the context of a multi-party action.2

[Guest guest]

Same here in the states, almost always settles,

never admit wrongdoing, drugs still on market despite presented

studies being misinforming and regulatory bodies being lied to.

The lawyers can hurt the companies a bit, since greed is the drug

companies apparent true manifesto.

On 1/24/2011 11:45 AM, jeremy9282 wrote:

Pharma sued by 23,600 persons over 30 years

NO case went to trial !

(The only winners, it seems, are

the fat cat lawyers)

here is an Atypical fat cat

but there are many others

"

In a succession of major English cases from the

mid 1970's, a total of around 23,600 claimants brought

claims in a succession of multiparty claims against

manufacturers involving DTP vaccine, Opren, Myodil

contrast media, benzodiazepine tranqullizers and the

Norplant subcutaneous contraceptive (Hodges, 1999).

However, no case proceeded as far as a final trial on

liability. The failure of the DTP vaccine, tranquillizer

and Norplant litigation in the UK can be contrasted with

the fact that the manufacturers settled similar claims

in the USA at enormous cost in order to avoid even

greater costs of years of litigation. In 2000, a case

was heard relating to the failure of a condom resulting

in pregnancy, but the judge held that the defendant's in

the case had never claimed that a condom was 100%

effective, and therefore the claim failed.

"

1 In March 2001, the first ever successful UK

product-related class action (

source - http://www.ippa.ws/IPPC1/BOOK/Chapter_15.pdfA v National

Blood Authority [2001] 3 All E.R. 289) under the Consumer

Protection Act strict liability was decided, when six

test cases (representing a total of 114 claimants)

obtained awards of up to £210,000 from Hepatitis C

infection from NHS blood transfusions. Goldberg (2002)

notes the implications of this case, as it was the first

opportunity of its kind in the UK to assess the problem

of strict medicinal product liability in the context of

a multi-party action.2

[Guest guest]

Well this one appears to be listed for a few weeks time Jim. GSK is taking Harvey & his 300 clients to the wire.

Seems he dumped 9700 clients a long the way & GSK say the remaining case has no merit.

Case details - & Ors v GlaxoKline

A group action against GlaxoKline UK where claimants are alleged to have suffered withdrawal effects when reducing, discontinuing or attempting to discontinue use of the anti-depressant Seroxat, and that such effects amount to personal injury.

Claimant lawyers:

Hugh partner partner Mark Harvey instructed 7 Bedford Row's Simeon Maskrey QC and n s.

Defendant lawyers:

Addleshaw Goddard partner Kelleher instructed Chambers' Gibson QC, Prashant Popat QC and Kinnier to represent GlaxoKline UK.

Hearing date: February for 12-14 weeks.

Judge and court: Mr Justice MacKay; Queen's Bench Division

> >> >> > Pharma sued by 23,600 persons over 30 years NO case went to> > trial !> > <http://bobfiddaman.blogspot.com/2011/01/pharma-sued-by-23600-persons-over-30.html>> >> >> > (The only winners, it seems, are the fat cat lawyers)> >> > <http://www.hughjames.com/images/THURSDAY008_m.JPG>> >> >> >> > here is an Atypical fat cat> > but there are many others> >> >> >> >> >> >> >> > */"/*> > */In a succession of major English cases from the mid 1970's, a total > > of around 23,600 claimants brought claims in a succession of > > multiparty claims against manufacturers involving DTP vaccine, Opren, > > Myodil contrast media, benzodiazepine tranqullizers and the Norplant > > subcutaneous contraceptive (Hodges, 1999). However, no case proceeded > > as far as a final trial on liability. The failure of the DTP vaccine, > > tranquillizer and Norplant litigation in the UK can be contrasted with > > the fact that the manufacturers settled similar claims in the USA at > > enormous cost in order to avoid even greater costs of years of > > litigation. In 2000, a case was heard relating to the failure of a > > condom resulting in pregnancy, but the judge held that the defendant's > > in the case had never claimed that a condom was 100% effective, and > > therefore the claim failed/*^. "> >> > ^1 In March 2001, the first ever successful UK product-related class > > action (> >> > ^source - http://www.ippa.ws/IPPC1/BOOK/Chapter_15.pdf /A v /National > > Blood Authority [2001] 3 All E.R. 289) under the Consumer Protection > > Act strict liability was decided, when six test cases (representing a > > total of 114 claimants) obtained awards of up to £210,000 from > > Hepatitis C infection from NHS blood transfusions. Goldberg (2002) > > notes the implications of this case, as it was the first opportunity > > of its kind in the UK to assess the problem of strict medicinal > > product liability in the context of a multi-party action.2 //> >> >> >>